KindlyMD (NASDAQ:NAKA – Get Free Report) and Walker & Dunlop (NYSE:WD – Get Free Report) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for KindlyMD and Walker & Dunlop, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KindlyMD | 1 | 1 | 3 | 0 | 2.40 |
| Walker & Dunlop | 1 | 0 | 5 | 0 | 2.67 |
KindlyMD presently has a consensus target price of $20.00, suggesting a potential upside of 100.20%. Walker & Dunlop has a consensus target price of $64.00, suggesting a potential upside of 68.03%. Given KindlyMD’s higher probable upside, research analysts plainly believe KindlyMD is more favorable than Walker & Dunlop.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KindlyMD | $1.82 million | 98.25 | -$52.23 million | ($35.85) | -0.28 |
| Walker & Dunlop | $1.23 billion | 1.06 | $57.08 million | $1.12 | 34.01 |
Walker & Dunlop has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Walker & Dunlop, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
KindlyMD has a beta of 15.99, meaning that its share price is 1,499% more volatile than the S&P 500. Comparatively, Walker & Dunlop has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.
Institutional and Insider Ownership
81.0% of Walker & Dunlop shares are held by institutional investors. 24.5% of KindlyMD shares are held by insiders. Comparatively, 4.0% of Walker & Dunlop shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares KindlyMD and Walker & Dunlop’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KindlyMD | -1,067.93% | -63.45% | -41.04% |
| Walker & Dunlop | 2.94% | 7.25% | 2.31% |
Summary
Walker & Dunlop beats KindlyMD on 10 of the 14 factors compared between the two stocks.
About KindlyMD
Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.
About Walker & Dunlop
Walker & Dunlop, Inc. is a holding company, which engages in the provision of commercial real estate and finance services. It operates through the following segments: Capital Markets, Servicing and Asset Management, and Corporate. The Capital Markets segment offers a comprehensive range of commercial real estate finance products to customers. The Servicing and Asset Management segment includes servicing and asset-managing and managing third-party capital investments. The Corporate segment consists primarily of the company’s treasury operations and other corporate-level activities. The company was founded by Oliver Walker and Laird Dunlop in 1937 and is headquartered in Bethesda, MD.
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
